butabarbital increases consequences of ifosfamide by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. CYP3A4 inducers may well raise the metabolism of ifosfamide to its Lively alkylating metabolites.This medication passes into breast milk and can have unwanted results with a nursing infant. Talk to your physician